Anti-Mouse TIM-2 – Purified in vivo PLATINUM™ Functional Grade

Anti-Mouse TIM-2 – Purified in vivo PLATINUM™ Functional Grade

Product No.: T763

- -
- -
Clone
RMT2-25
Target
TIM-2
Formats AvailableView All
Product Type
Hybridoma Monoclonal Antibody
Alternate Names
T-cell immunoglobulin and mucin domain-containing protein 2, TIMD-2
Isotype
Rat IgG2a κ
Applications
Agonist
,
B
,
FA
,
FC
,
IP
,
WB

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Mouse
Host Species
Rat
Recommended Dilution Buffer
Immunogen
TIM-2-Ig chimera protein consisting of extracellular domain residues 1-230 and the Fc portion of mouse IgG2
Product Concentration
≥ 5.0 mg/ml
Endotoxin Level
<0.5 EU/mg as determined by the LAL method
Purity
≥98% monomer by analytical SEC
>95% by SDS Page
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
State of Matter
Liquid
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Pathogen Testing
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Leinco’s Purified Functional PLATINUM<sup>TM</sup> antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles.
Regulatory Status
Research Use Only
Country of Origin
USA
Shipping
2 – 8° C Wet Ice
Additional Applications Reported In Literature ?
Agonist,
B,
FA,
FC,
IP,
WB
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Description

Specificity
RMT2-25 activity is directed against mouse TIM-2.
Background
The T cell/transmembrane, immunoglobulin, and mucin (TIM) family plays a critical role in immune response, transplant tolerance, autoimmunity, and allergy and asthma regulation1. The TIM family consists of eight members, including TIM-2 which is only found in rodent genomes. TIM-2 is likely a gene duplication of TIM-1. TIM-2 is a type I cell surface glycoprotein that has an N-terminal immunoglobulin-like (Ig) domain, a mucin domain with O- and N-linked glycosylations, a single transmembrane domain, and a cytoplasmic region with tyrosine phosphorylation motif. Unlike other TIM family proteins, TIM-2 does not bind PtdSer. TIM-2 is a receptor for H-ferritin. TIM-2 functions as a negative regulator of T cell activation and Th2 responses.

RMT2-25 was generated by immunizing Sprague Dawley rats with a TIM-2-Ig chimera protein consisting of murine TIM-2-Ig (extracellular domain residues 1-230) and the Fc portion of mouse IgG2a2 . LN cells were fused with P3U1 myeloma cells. The RMT2-25 hybridoma was selected using flow cytometry, based on reactivity to mouse TIM-2 transfected cells, but not parental cells. RMT2-25 inhibits the binding of H-ferritin to TIM-2. RMT2-25 also significantly enhances B cell proliferation and activation in vitro by agonistic stimulation of TIM-2.

Antigen Distribution
TIM-2 is expressed by activated T cells, particularly after differentiation under Th2 conditions. TIM-2 is not expressed by T cells differentiated under Th1 conditions. TIM-2 is also expressed by splenic and germinal B cells. Other cells expressing TIM-2 include epithelial cells in the liver and kidney as well as oligodendrocytes.
Ligand/Receptor
Sema4A, H-ferritin
NCBI Gene Bank ID
UniProt.org
Research Area
Autoimmune
.
Immunology
.
Immunoglobulins

Leinco Antibody Advisor

Powered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments.

Clone RMT2-25 is a rat monoclonal antibody that specifically recognizes mouse TIM-2 (T-cell immunoglobulin mucin 2), a transmembrane glycoprotein expressed by activated lymphocytes, particularly upregulated in Th2 cells and downregulated in Th1 cells. In in vivo mouse studies, RMT2-25 is primarily used for functional blocking or agonist experiments to investigate the immunoregulatory role of TIM-2 in T cell activation, Th2-biased immune responses, and diseases such as allergy, asthma, and autoimmunity.

Key uses and context in vivo:

  • Blocking or modulating TIM-2 activity: RMT2-25 can be administered to mice to antagonize or agonize TIM-2, thereby influencing T cell activation and Th2 responses, which are crucial in allergy, atopic disease, and transplant tolerance research.
  • Disease models: The antibody is especially relevant in mouse models of respiratory disease, autoimmune disorders, or transplantation studies where the role of Th2 cells and their regulation by TIM-2 is a key question.
  • Target antigen: TIM-2, which is exclusively found in rodent genomes and regulates immune function by acting as a negative regulator of Th2 cells, serving as a receptor for Semaphorin 4A, and being involved in dendritic and B cell signaling.

Typical experimental protocol:

  • RMT2-25 is administered via intraperitoneal (i.p.) or intravenous (i.v.) injection as a functional grade, purified antibody.
  • Dosing and timing are disease- or model-specific and detailed in lot-specific datasheets or prior publications; optimal conditions must be empirically determined by the investigator for each study.
  • Functional assays include measuring changes in Th2 cytokine production, T cell proliferation, and disease symptoms or outcomes in relevant mouse models.

Summary Table:

CloneTargetTypical ApplicationEffects Studied
RMT2-25Mouse TIM-2in vivo blocking/agonistTh2 response, allergy, autoimmunity

RMT2-25 is thus a tool for investigating the role of TIM-2 in rodent immune regulation by modulating its function in mouse in vivo disease models.

The correct storage temperature for sterile packaged clone RMT2-25 (TIMD2 Monoclonal Antibody) is:

  • 4°C for short-term storage
  • -20°C for long-term storage, while avoiding freeze/thaw cycles.

Short-term typically refers to storage over days to a few weeks, while long-term means months or longer. Always avoid repeated freeze/thaw cycles to maintain antibody integrity. Protect from light if the antibody is conjugated (e.g., FITC-labeled).

RMT2-25 is a monoclonal antibody that specifically targets mouse TIM-2 (T-cell immunoglobulin mucin 2), frequently used in immunological research to study T cell activation, Th2 immune responses, and the function or expression of TIM-2. In the literature, several other antibodies or proteins are often used together with RMT2-25, either as controls, for cell subset identification, or to compare different receptor signaling pathways.

Commonly co-used antibodies or proteins include:

  • Anti-CD3 and anti-CD28: These antibodies are frequently used to stimulate or activate T cells in culture, enabling researchers to assess how TIM-2 signaling modulates T cell function alongside primary activation signals.
  • Anti-TIM-1 (RMT1-10): Since TIM-1 is a related family member expressed on T cells, anti-TIM-1 antibodies are often used in parallel for comparative studies of TIM family regulation of immunity, especially Th1/Th2 differentiation.
  • Anti-B220/CD45R or other B cell markers: TIM-2 is expressed on germinal center B cells, so antibodies against B cell markers are commonly used to identify B cell subsets in conjunction with RMT2-25 staining.
  • Semaphorin 4A: This is a protein ligand for TIM-2, sometimes added exogenously or blocked in experiments to probe specific signaling interactions.
  • Fc Receptor Blockers (e.g., anti-CD16/CD32): Used to prevent nonspecific Fc-mediated binding of rat antibodies like RMT2-25 in mouse samples, ensuring more specific staining or functional readouts.

Additionally, in broader research on receptor-mediated transcytosis (RMT) and related immune processes, other frequently used antibodies include those targeting:

  • Transferrin receptor (TfR/CD71)
  • Insulin or IGF-1 receptors
  • GLUT1 (glucose transporter 1)
  • Low-density lipoprotein receptor (LDLR) and related proteins

These latter antibodies are generally used in parallel experiments or as alternative RMT pathway probes, particularly in blood-brain barrier or endocytosis research.

Overall, the most commonly paired reagents with RMT2-25 are anti-TIM-1, anti-CD3, anti-CD28, B cell markers like B220, Fc-block reagents, and defined protein ligands (such as Semaphorin 4A), all chosen based on the specific immune subset or signaling pathway being interrogated.

Key findings from scientific literature citing clone RMT2-25 center on its use as a monoclonal antibody targeting mouse TIM-2 (T-cell immunoglobulin mucin 2), a transmembrane glycoprotein and member of the immunoglobulin superfamily expressed primarily in activated lymphocytes.

  • Functional Characterization of TIM-2:

    • TIM-2 is preferentially up-regulated in Th2 cells (a subset of T-helper cells involved in allergic responses) and down-regulated in Th1 cells.
    • TIM-2 acts as a negative regulator of Th2 cells, impacting atopic disease and Th2-biased immune responses.
    • TIM-2 is also a receptor for Semaphorin 4A, which influences axonal guidance in neurons and enhances T cell activation.
  • Role in B Lymphocyte Biology and Autoimmune Disease:

    • RMT2-25, along with related clones, was used to study how anti-TIM-2 monoclonal antibody treatment affects immune responses in a murine model of collagen-induced arthritis (CIA).
    • Administration of anti-TIM-2 mAb, particularly in the early phase of disease, exacerbated arthritis severity by increasing serum levels of anti-collagen (anti-CII) antibodies without affecting Th1 or Th17 cell development.
    • TIM-2 expression is found on splenic B cells and is up-regulated by stimulation, while CD4 T cells do not express TIM-2.
    • Anti-TIM-2 mAb (RMT2-25) enhanced proliferation and antibody production of activated B cells in vitro, indicating a direct role of TIM-2 signaling in B cell function.
  • Technical Details and Use Cases:

    • RMT2-25 is a rat IgG2a/? monoclonal antibody.
    • Its specificity for mouse TIM-2 enables precise functional studies in mouse models of immunity, development, and autoimmune disease.
    • It exhibits strong blocking activity among tested clones (RMT2-14, RMT2-25, RMT2-26).

In summary: Literature utilizing clone RMT2-25 identifies TIM-2 as an important regulator of Th2 responses and B cell activation, and implicates TIM-2 signaling in antibody production and autoimmune disease severity in mice. RMT2-25 is recognized as a valuable tool for dissecting TIM-2 function in immunological research.

References & Citations

1 Freeman GJ, Casasnovas JM, Umetsu DT, et al. Immunol Rev. 235(1):172-189. 2010.
2 Kawamoto T, Abe Y, Ito J, et al. Arthritis Res Ther. 13(2):R47. 2011.
Agonist
B
FA
Flow Cytometry
Immunoprecipitation Protocol
General Western Blot Protocol

Certificate of Analysis

Formats Available

- -
- -
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.